With the number of stem cell-based therapies emerging on the increase, the need for novel and efficient delivery technologies to enable therapies to remain in damaged tissue and exert their therapeutic benefit for extended periods, has become a key requirement for their translation. Hydrogels, and in particular, thermoresponsive hydrogels, have the potential to act as such delivery systems. Thermoresponsive hydrogels, which are polymer solutions that transform into a gel upon a temperature increase, have a number of applications in the biomedical field due to their tendency to maintain a liquid state at room temperature, thereby enabling minimally invasive administration and a subsequent ability to form a robust gel upon heating to physiological temperature. However, various hurdles must be overcome to increase the clinical translation of hydrogels as a stem cell delivery system, with barriers including their low tensile strength and their inadequate support of cell viability and attachment. In order to address these issues, a methylcellulose based hydrogel was formulated in combination with collagen and beta glycerophosphate, and key development issues such as injectability and sterilisation processes were examined. The polymer solution underwent thermogelation at ~36 °C as determined by rheological analysis, and when gelled, was sufficiently robust to resist significant disintegration in the presence of phosphate buffered saline (PBS) while concomitantly allowing for diffusion of methylene blue dye solution into the gel. We demonstrate that human mesenchymal stem cells (hMSCs) encapsulated within the gel remained viable and showed raised levels of dsDNA at increasing time points, an indication of cell proliferation. Mechanical testing showed the “injectability”, i.e. force required for delivery of the polymer solution through devices such as a syringe, needle or catheter. Sterilisation of the freeze-dried polymer wafer via gamma irradiation showed no adverse effects on the formed hydrogel characteristics. Taken together, these results indicate the potential of this gel as a clinically translatable delivery system for stem cells and therapeutic molecules in vivo.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
human mesenchymal stem cells
standard error of mean
Orlando G, Wood KJ, Stratta RJ, Yoo JJ, Atala A, Soker S. Regenerative medicine and organ transplantation: past, present, and future. Transplantation. 2011;91(12):1310–7.
Lau AN, Goodwin M, Kim CF, Weiss DJ. Stem cells and regenerative medicine in lung biology and diseases. Mol Ther. 2012;20(6):1116–30.
Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105(3):369–77.
D. N. Kotton, B. Y. Ma, W. V Cardoso, E. A. Sanderson, R. S. Summer, M. C. Williams, and A. Fine, “Bone marrow-derived cells as progenitors of lung alveolar epithelium.,” Development, vol. 128, no. 24, pp. 5181–5188, 2001.
Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701–5.
Antunes MA, Laffey JG, Pelosi P, Rocco PRM. Mesenchymal stem cell trials for pulmonary diseases. J Cell Biochem. 2014;115(6):1023–32.
O’Neill HS, Gallagher LB, O’Sullivan J, Whyte W, Curley C, Dolan E, Hameed A, O’Dwyer J, Payne C, O’Reilly D, Ruiz-Hernandez E, Roche ET, O’Brien FJ, Cryan SA, Kelly H, Murphy B, Duffy GP. Biomaterial-enhanced cell and drug delivery: lessons learned in the cardiac field and future perspectives. Adv Mater. 2016:5648–61.
Ye Z, Zhou Y, Cai H, Tan W. Myocardial regeneration: roles of stem cells and hydrogels. Adv Drug Deliv Rev. 2011;63(8):688–97.
Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol. 2005;23(7):845–56.
Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol. 2001;33(5):907–21.
Malliaras K, Marbán E. Cardiac cell therapy: where we’ve been, where we are, and where we should be headed. Br Med Bull. 2011;98:161–85.
Wang Q-D, Sjöquist P-O. Myocardial regeneration with stem cells: pharmacological possibilities for efficacy enhancement. Pharmacol Res. 2006;53(4):331–40.
Hastings CL, Roche ET, Ruiz-Hernandez E, Schenke-Layland K, Walsh CJ, Duffy GP. Drug and cell delivery for cardiac regeneration. Adv Drug Deliv Rev. 2014;84:85–106.
Liu Z, Wang H, Wang Y, Lin Q, Yao A, Cao F, Li D, Zhou J, Duan C, Du Z, Wang Y, Wang C. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials. 2012;33(11):3093–106.
A. C. Gaffey, M. H. Chen, C. M. Venkataraman, A. Trubelja, C. B. Rodell, P. V Dinh, G. Hung, J. W. MacArthur, R. V Soopan, J. A. Burdick, and P. Atluri, “Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.,” J Thorac Cardiovasc Surg, vol. 150, no. 5, pp. 1268–1277, 2015.
Hoare TR, Kohane DS. Hydrogels in drug delivery: Progress and challenges. Polymer (Guildf). 2008;49(8):1993–2007.
Klouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm. 2008;68(1):34–45.
Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, Leroux JC, Atkinson BL, Binette F, Selmani A. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials. 2000;21(21):2155–61.
Hastings CL, Kelly HM, Murphy MJ, Barry FP, O’Brien FJ, Duffy GP. Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia. J Control Release. 2012;161(1):73–80.
Zhang Z, Ni J, Chen L, Yu L, Xu J, Ding J. Biodegradable and thermoreversible PCLA-PEG-PCLA hydrogel as a barrier for prevention of post-operative adhesion. Biomaterials. 2011;32(21):4725–36.
Elstad NL, Fowers KD. OncoGel (ReGel/paclitaxel)--clinical applications for a novel paclitaxel delivery system. Adv Drug Deliv Rev. 2009;61(10):785–94.
Shive MS, Hoemann CD, Restrepo A, Hurtig MB, Duval N, Ranger P, Stanish W, Buschmann MD. BST-CarGel: in situ ChondroInduction for cartilage repair. Oper Tech Orthop. 2006;16(4):271–8.
Shalhoub J, Thapar A, Davies AH. The use of reverse thermosensitive polymer (LeGoo) for temporary vessel occlusion in clampless peripheral vascular surgery. Vasc Endovasc Surg. 2011;45(5):422–5.
Buwalda SJ, Boere KWM, Dijkstra PJ, Feijen J, Vermonden T, Hennink WE. Hydrogels in a historical perspective: from simple networks to smart materials. J Control Release. 2014;190:254–73.
Higuchi A, Sugiyama K, Yoon BO, Sakurai M, Hara M, Sumita M, Sugawara S, Shirai T. Serum protein adsorption and platelet adhesion on pluronic™-adsorbed polysulfone membranes. Biomaterials. 2003;24(19):3235–45.
Ruel-Gariépy E, Leroux J-C. In situ-forming hydrogels--review of temperature-sensitive systems. Eur J Pharm Biopharm. 2004;58(2):409–26.
Yu L, Ding J. Injectable hydrogels as unique biomedical materials. Chem Soc Rev. 2008;37(8):1473–81.
Supper S, Anton N, Seidel N, Riemenschnitter M, Curdy C, Vandamme T. Thermosensitive chitosan/glycerophosphate-based hydrogel and its derivatives in pharmaceutical and biomedical applications. Expert Opin Drug Deliv. 2014;11(2):249–67.
Tang Y, Wang X, Li Y, Lei M, Du Y, Kennedy JF, Knill CJ. Production and characterisation of novel injectable chitosan/methylcellulose/salt blend hydrogels with potential application as tissue engineering scaffolds. Carbohydr Polym. 2010;82(3):833–41.
Chenite A, Buschmann M, Wang D, Chaput C, Kandani N. Rheological characterisation of thermogelling chitosan / glycerol-phosphate solutions. Carbohydr Polym. 2001;46:39–47.
Huang CC, Liao ZX, Chen DY, Hsiao CW, Chang Y, Sung HW. Injectable cell constructs fabricated via culture on a thermoresponsive methylcellulose hydrogel system for the treatment of ischemic diseases. Adv Healthc Mater. 2014;3(8):1133–48.
Thirumala S, Gimble J, Devireddy R. Methylcellulose based thermally reversible hydrogel system for tissue engineering applications. Cells. 2013;2:460–75.
Wallace D. Collagen gel systems for sustained delivery and tissue engineering. Adv Drug Deliv Rev. 2003;55(12):1631–49.
Wang L, Stegemann JP. Thermogelling chitosan and collagen composite hydrogels initiated with beta-glycerophosphate for bone tissue engineering. Biomaterials. 2010;31(14):3976–85.
Lee KY, Mooney DJ. Hydrogels for Tissue Engineering. Chem Rev. 2001;101(7):1869–80.
Camci-Unal G, Annabi N, Dokmeci MR, Liao R, Khademhosseini A. Hydrogels for cardiac tissue engineering. NPG Asia Mater. 2014;6(5):e99.
Liu X, Ma PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng. 2004;32(3):477–86.
Burdick JA, Anseth KS. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials. 2002;23(22):4315–23.
Nichols JE, Kojima K, Bonassar LJ, Dargon P, Roy AK, Vacant MP, et al. Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. Tissue Eng. 2006;12(5):1213–25.
O’Brien F. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. Biomaterials. Mar. 2004;25(6):1077–86.
Duffy GP, Ahsan T, O’Brien T, Barry F, Nerem RM. Bone marrow-derived mesenchymal stem cells promote angiogenic processes in a time- and dose-dependent manner in vitro. Tissue Eng. Part A. 2009;15(9):2459–70.
C. of Europe, European Pharmacopoeia, 5.0., no. 1. Strasbourg, 2005.
Bramley K, Pisani MA, Murphy TE, Araujo KL, Homer RJ, Puchalski JT. Endobronchial ultrasound-guided cautery-assisted transbronchial forceps biopsies: safety and sensitivity relative to transbronchial needle aspiration. Ann Thorac Surg. 2016;101(5):1870–6.
Nilsen T, Hermann M, Eriksen CS, Dagfinrud H, Mowinckel P, Kjeken I. Grip force and pinch grip in an adult population: reference values and factors associated with grip force. Scand J Occup Ther. 2012;19(3):288–96.
Rungseevijitprapa W, Bodmeier R. Injectability of biodegradable in situ forming microparticle systems (ISM). Eur J Pharm Sci. 2009;36(4–5):524–31.
Lutolf MP. Biomaterials: spotlight on hydrogels. Nat Mater. 2009;8(6):451–3.
E. T. Roche, C. L. Hastings, S. A. Lewin, D. E. Shvartsman, Y. Brudno, N. V Vasilyev, F. J. O’Brien, C. J. Walsh, G. P. Duffy, and D. J. Mooney, “Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart.,” Biomaterials, vol. 35, no. 25, pp. 6850–6858, 2014.
Aguado BA, Mulyasasmita W, Su J, Lampe KJ, Heilshorn SC. Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng Part A. 2012;18(7–8):806–15.
O’Brien FJ. Biomaterials & scaffolds for tissue engineering. Mater Today. 2011;14(3):88–95.
Burdick JA, Mauck RL, Gerecht S. To serve and protect: hydrogels to improve stem cell-based therapies. Cell Stem Cell. 2016;18(1):13–5.
Tate MC, Shear DA, Hoffman SW, Stein DG, LaPlaca MC. Biocompatibility of methylcellulose-based constructs designed for intracerebral gelation following experimental traumatic brain injury. Biomaterials. 2001;22(10):1113–23.
Xu Y, Wang C, Tam KC, Li L. Salt-assisted and salt-suppressed sol-gel transitions of methylcellulose in water. Langmuir. 2004;20(3):646–52.
Kobayashi K, Huang C, Lodge TP. Thermoreversible gelation of aqueous methylcellulose solutions. Macromolecules. 1999;32(21):7070–7.
Chen K, Baker AN, Vyazovkin S. Concentration effect on temperature dependence of gelation rate in aqueous solutions of methylcellulose. Macromol Chem Phys. 2009;210(3–4):211–6.
Yang Y-L, Leone LM, Kaufman LJ. Elastic moduli of collagen gels can be predicted from two-dimensional confocal microscopy. Biophys J. 2009;97(7):2051–60.
Helary C, Bataille I, Abed A, Illoul C, Anglo A, Louedec L, Letourneur D, Meddahi-Pellé A, Giraud-Guille MM. Concentrated collagen hydrogels as dermal substitutes. Biomaterials. 2010;31(3):481–90.
Friess W. Collagen--biomaterial for drug delivery. Eur J Pharm Biopharm. 1998;45(2):113–36.
Tang Y-F, Du Y-M, Hu X-W, Shi X-W, Kennedy JF. Rheological characterisation of a novel thermosensitive chitosan/poly(vinyl alcohol) blend hydrogel. Carbohydr Polym. 2007;67(4):491–9.
Edsman K, Carlfors J, Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci. 1998;6(2):105–12.
Nowak AP, Breedveld V, Pakstis L, Ozbas B, Pine DJ, Pochan D, et al. Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptide amphiphiles. Nature. 2002;417(6887):424–8.
Lin H-R, Sung K. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Control Release. 2000;69(3):379–88.
Jeong B, Kim SW, Bae YH. Thermosensitive sol–gel reversible hydrogels. Adv Drug Deliv Rev. 2002;54(1):37–51.
Kleinman HK, Klebe RJ, Martin GR. Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol. 1981;88(3):473–85.
Gupta D, Tator CH, Shoichet MS. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials. 2006;27(11):2370–9.
Lee DW, Choi WS, Byun MW, Park HJ, Yu Y-M, Lee CM. Effect of gamma-irradiation on degradation of alginate. J Agric Food Chem. 2003;51:4819–23.
Wasikiewicz JM, Yoshii F, Nagasawa N, Wach RA, Mitomo H. Degradation of chitosan and sodium alginate by gamma radiation, sonochemical and ultraviolet methods. Radiat Phys Chem. 2005;73(5):287–95.
Sanina C, Hare JM. Mesenchymal stem cells as a biological drug for heart disease: where are We with cardiac cell-based therapy? Circ Res. 2015;117(3):229–33.
A bursary to allow for this work to be carried out was provided by the School of Pharmacy, Royal College of Surgeons in Ireland.
Conflict of interests
The authors declare that they have no conflict of interest.
This research was funded by Science Foundation Ireland (SFI) Investigator Award 13/IA/840
About this article
Cite this article
Payne, C., Dolan, E.B., O’Sullivan, J. et al. A methylcellulose and collagen based temperature responsive hydrogel promotes encapsulated stem cell viability and proliferation in vitro. Drug Deliv. and Transl. Res. 7, 132–146 (2017). https://doi.org/10.1007/s13346-016-0347-2
- Mesenchymal stem cells
- Gamma irradiation